 | Up a level |
Scheiner, Bernhard; Roessler, Daniel; Phen, Samuel; Lim, Mir; Pomej, Katharina; Pressiani, Tiziana; Cammarota, Antonella; Fründt, Thorben W.; von Felden, Johann; Schulze, Kornelius; Himmelsbach, Vera; Finkelmeier, Fabian; Deibel, Ansgar; Siebenhüner, Alexander R.; Shmanko, Kateryna; Radu, Pompilia; Schwacha-Eipper, Birgit; Ebert, Matthias P.; Teufel, Andreas; Djanani, Angela; ... (2023). Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma. JHEP reports, 5(1), p. 100620. Elsevier 10.1016/j.jhepr.2022.100620
Muñoz-Martínez, Sergio; Sapena, Victor; Forner, Alejandro; Bruix, Jordi; Sanduzzi-Zamparelli, Marco; Ríos, José; Bouattour, Mohamed; El Kassas, Mohamed; Leal, Cassia Regina Guedes; Mocan, Tudor; Nault, Jean-Charles; Alves, Rogerio Camargo Pinheiro; Reeves, Helen L; da Fonseca, Leonardo; García-Juárez, Ignacio; Pinato, David J; Varela, María; Alqahtani, Saleh A; Alvares-da-Silva, Mario Reis; Bandi, Juan C; ... (2022). Outcome of liver cancer patients with SARS-CoV-2 infection. Liver international, 42(8), pp. 1891-1901. Wiley 10.1111/liv.15320
Pfister, Dominik; Núñez, Nicolás Gonzalo; Pinyol, Roser; Govaere, Olivier; Pinter, Matthias; Szydlowska, Marta; Gupta, Revant; Qiu, Mengjie; Deczkowska, Aleksandra; Weiner, Assaf; Müller, Florian; Sinha, Ankit; Friebel, Ekaterina; Engleitner, Thomas; Lenggenhager, Daniela; Moncsek, Anja; Heide, Danijela; Stirm, Kristin; Kosla, Jan; Kotsiliti, Eleni; ... (2021). NASH limits anti-tumour surveillance in immunotherapy-treated HCC. Nature, 592(7854), pp. 450-456. Springer Nature 10.1038/s41586-021-03362-0
